NCT01813656

An Study of Aripiprazole in the Treatment of Methamphetamine Dependence

A Multiple-Center, Randomized, Double-Blind Study of Aripiprazole for Treatment of Methamphetamine Dependence

• Status: Terminated
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 10 (actual)
• Sponsor: Wei Hao · Academic / Other
• Sex: All
• Age: 19 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

Methamphetamine substance use is common worldwide. No approved pharmacologic treatments for methamphetamine dependence exist. Aripiprazole are Second generation antipsychotics，but have different pharmacological effects of neurotransmitters.To determine whether mirtazapine would reduce methamphetamine use among mehtamphetamine addicts.

Detailed description

Methods:A Multiple-Center, Randomized, Double-Blind.

Conditions

• Methamphetamine Dependence

Interventions

Type	Name	Description
DRUG	Aripiprazole	Aripiprazole group,5mg/pill,10mg/day non-forced titration method,last 12weeks
DRUG	placebo	placebo group,5mg/pill,10mg/day non-forced titration method,last 12 weeks

Timeline

• Start date: 2012-09-01
• Primary completion: 2013-12-01
• Completion: 2014-02-01
• First posted: 2013-03-19
• Last updated: 2015-02-04

Locations

1 site across 1 country: China